Reporting standards for balloon test occlusion

When carotid artery BTO is clinically tolerated, the morbidity and mortality associated with permanent arterial occlusion are reduced but, unfortunately, not eliminated. Since the report of endovascular temporary arterial occlusion presented by Serbinenko 7 was published, a variety of adjunctive met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurointerventional surgery 2013-11, Vol.5 (6), p.503-505
Hauptverfasser: Narayanan, S, Singer, R, Abruzzo, T A, Hussain, M S, Powers, C J, Prestigiacomo, C J, Heck, D V, Sunshine, J L, Kelly, M, Jayaraman, M V, Meyers, P M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:When carotid artery BTO is clinically tolerated, the morbidity and mortality associated with permanent arterial occlusion are reduced but, unfortunately, not eliminated. Since the report of endovascular temporary arterial occlusion presented by Serbinenko 7 was published, a variety of adjunctive methods have been tested to improve the sensitivity and specificity of clinical neurologic evaluation alone for the detection of insufficient cerebral blood flow to allow safe permanent arterial occlusion. Pharmacologic induction of hypotension during BTO has also been used to attempt to elicit clinical signs of inadequate perfusion. 30-32 Indications Indications for BTO include: a fusiform aneurysm/pseudoaneurysm ineligible for treatment with parent vessel sparing techniques; a vessel at risk for occlusion during a complex surgical/endovascular procedure; life threatening hemorrhage related to trauma, neoplasm, radiation necrosis, or infection; cranial and cervical neoplasms with ICA involvement; arterial dissection with continued embolism when antiplatelets/anticoagulation are contraindicated; and direct carotid-cavernous fistula, which may not be treatable with preservation of the parent artery.
ISSN:1759-8478
1759-8486
DOI:10.1136/neurintsurg-2013-010848